|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.51 USD | +1.94% |
|
+0.14% | +7.17% |
| 22/07 | Conmed Says AirSeal Cleared for Use With Intuitive da Vinci 5 Hex Cannula | MT |
| 15/07 | Conmed Shares Rise After Company Mulls Sale Amid Takeover Interest | MT |
Company Valuation: CONMED Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,146 | 2,702 | 3,368 | 2,114 | 1,257 | 1,310 | - | - |
| Change | - | -34.83% | 24.64% | -37.22% | -40.53% | 4.2% | - | - |
| Enterprise Value (EV) 1 | 4,810 | 3,728 | 4,317 | 2,995 | 2,051 | 2,004 | 1,889 | 1,762 |
| Change | - | -22.5% | 15.81% | -30.62% | -31.52% | -2.31% | -5.74% | -6.71% |
| P/E | 73.1x | -33.1x | 53.7x | 16.1x | 26.9x | 10.9x | 9.39x | 8.43x |
| PBR | 5.26x | 3.57x | 4.04x | 2.2x | 1.1x | 1.11x | 0.97x | 0.85x |
| PEG | - | 0x | -0x | 0x | -0.4x | 0x | 0.6x | 0.7x |
| Capitalization / Revenue | 4.1x | 2.58x | 2.71x | 1.62x | 0.91x | 0.96x | 0.91x | 0.87x |
| EV / Revenue | 4.76x | 3.57x | 3.47x | 2.29x | 1.49x | 1.47x | 1.32x | 1.16x |
| EV / EBITDA | 24.4x | 19.8x | 18.3x | 11.3x | 7.44x | 7.36x | 6.45x | 6.36x |
| EV / EBIT | 33.6x | 28.4x | 24.8x | 14.8x | 9.5x | 9.87x | 8.53x | 7.15x |
| EV / FCF | 49.6x | 322x | 40.6x | 19.5x | 13.6x | 10.3x | 11.5x | 10.1x |
| FCF Yield | 2.01% | 0.31% | 2.46% | 5.14% | 7.36% | 9.72% | 8.67% | 9.87% |
| Dividend per Share 2 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | - | - | - |
| Rate of return | 0.56% | 0.9% | 0.73% | 1.17% | 1.97% | - | - | - |
| EPS 2 | 1.94 | -2.68 | 2.04 | 4.25 | 1.51 | 3.98 | 4.635 | 5.16 |
| Distribution rate | 41.2% | -29.9% | 39.2% | 18.8% | 53% | - | - | - |
| Net sales 1 | 1,011 | 1,045 | 1,245 | 1,307 | 1,375 | 1,362 | 1,434 | 1,514 |
| EBITDA 1 | 197.2 | 188.7 | 235.4 | 265.6 | 275.9 | 272.3 | 292.9 | 277.2 |
| EBIT 1 | 143.3 | 131.3 | 174.4 | 202.8 | 216 | 203 | 221.4 | 246.4 |
| Net income 1 | 62.54 | -80.58 | 64.46 | 132.4 | 47.06 | 120.5 | 140.1 | 153.6 |
| Net Debt 1 | 663.8 | 1,026 | 949.6 | 881.3 | 794.1 | 694 | 579 | 452.2 |
| Reference price 2 | 141.76 | 88.64 | 109.51 | 68.44 | 40.60 | 43.51 | 43.51 | 43.51 |
| Nbr of stocks (in thousands) | 29,247 | 30,482 | 30,752 | 30,891 | 30,968 | 30,109 | - | - |
| Announcement Date | 26/1/22 | 2/2/23 | 31/1/24 | 5/2/25 | 28/1/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 10.72x | 1.45x | 7.27x | -.--% | 1.29B | |
| 29.22x | 4.03x | 15.68x | 2.51% | 180B | |
| 18.88x | 3.31x | 11.63x | 3.57% | 107B | |
| 17.24x | 0.19x | 12.17x | 0.77% | 60.29B | |
| 30.98x | 7.52x | 19.65x | 1.29% | 50.19B | |
| 38.96x | 3.1x | 10.58x | 2.46% | 43.08B | |
| 37.15x | 1.36x | 11.97x | 0.26% | 32.77B | |
| 29.08x | 5.2x | 16.59x | -.--% | 27.61B | |
| 38.27x | 6.7x | 24x | 0.28% | 23.1B | |
| 23.57x | 3.45x | 12.39x | 1.23% | 20.86B | |
| Average | 27.41x | 3.63x | 14.19x | 1.24% | 54.52B | |
| Weighted average by Cap. | 27.40x | 3.70x | 14.49x | 2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CNMD Stock
- Valuation CONMED Corporation
Select your edition
All financial news and data tailored to specific country editions
